Miglustat (CoTherix, Inc.)
Welcome to the PulseAid listing for the Miglustat drug offered from CoTherix, Inc.. This Glucosylceramide Synthase Inhibitor [EPC],Glucosylceramide Synthase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | CoTherix, Inc. |
| NON-PROPRIETARY NAME: | miglustat |
| SUBSTANCE NAME: | MIGLUSTAT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Glucosylceramide Synthase Inhibitor [EPC],Glucosylceramide Synthase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2016-12-09 |
| END MARKETING DATE: | 0000-00-00 |
Miglustat HUMAN PRESCRIPTION DRUG Details:
| Item Description | Miglustat from CoTherix, Inc. |
| LABELER NAME: | CoTherix, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2016-12-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10148-201_dc42b7e1-cba4-4db8-85e8-0d72077bb8df |
| PRODUCT NDC: | 10148-201 |
| APPLICATION NUMBER: | NDA021348 |
Other MIGLUSTAT Pharmaceutical Manufacturers / Labelers:
